PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Atenolol - Arrhythmias

PAD Profile : Atenolol - Arrhythmias

Keywords :
beta-blockers
Brand Names Include :
Tenormin

Traffic Light Status

Status 1 of 2.

Status :
Green
Formulations :
  • Oral solution
  • Tablets
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Status 2 of 2.

Status :
Red
Formulations :
  • Intravenous infusion
  • Intravenous injection (IV)
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Guidelines

No guidelines returned.

Other Drugs

Other Indications

No indications returned.

Additional Documents

No additional documents returned.

Committee Recommendations

Date
Committee Name
Narrative
03 May 2017
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
Atenolol has been considered by the PCN and has been assigned a GREEN traffic light status, within its LICENSED indication(s). NOTE - the branded product (Tenormin) was considered BLACK at the PCN in May 2017.

Associated BNF Codes

02. Cardiovascular System
02.04.00. Beta-adrenoceptor blocking drugs
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
Learn More